Log In | Register
CBER proposed rule eases restrictions on Constituent Materials in vaccines and biologicals.
US rules on adjuvants and other biologicals could be loosened under FDA proposals
Seeded on Thu Apr 1, 2010 1:22 PM EDT
Article Source: The Flu Case- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
The Article Continues:
Biologics manufacturers could gain some leeway on constituent materials under a rule the FDA has proposed in response to technological advances in development and manufacturing. Current regulations on constituents such as preservatives, diluents, adjuvants, extraneous protein and antibiotics in biological products may be "unnecessarily restrictive," according to the FDA notice to be published in the March 30 Federal Register. Comments are due June 28. See proposed rule at http://www.fdanews.com/ext/files/2010-07073_PI.pdf
Drug Industry Daily
http://www.fdanews.com/newsletter/article?issueId=13560&articleId=125719
- 1 vote
#1 - Thu Apr 1, 2010 1:25 PM EDTYou're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
